Erectile Dysfunction Drugs Market Segments: By Drug Type (Viagra (sildenafil citrate), Cialis (Tadalafil), Staxyn/Levitra (vardenafil), Stendra/Spedra (avanafil), Zydena (udenafil), Vitaros (Alprostadil Cream) and Others); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Sales); By Mode of Administration (Oral Medications, Topical Medications , Injections and Others) and Region - Global Analysis of Market Size, Share & Trends for 2014 - 2020 and Forecasts to 2030
[ 170 + Pages Research Report ] Erectile Dysfunction Drugs Market to surpass USD XXXX million by 2030 from USD XXXX million in 2020 at a CAGR of XX.X% in the coming years, i.e., 2021-30.
Inability to maintain and develop an erection for satisfactory sexual intercourse or activity refers to erectile dysfunction. The main causes of erectile dysfunction are high blood pressure, diabetes, high cholesterol, or depression. The symptoms of erectile dysfunction include trouble in maintaining an erection, difficulty in achieving an erection, and a reduced interest in sex. There are many medications available to treat erectile dysfunction which are commonly known as erectile dysfunction drugs. Sildenafil (Viagra), tadalafil (Cialis), and vardenafil (Levitra) are some of the oral medications that reverse erectile dysfunction by improving the effects of nitric oxide, a natural chemical that a body produces that relaxes the muscles of the penis. This increases blood flow and allows them to get an erection in response to sexual stimulation.
Global Erectile Dysfunction Drugs Market to surpass USD XXXX million by 2030 from USD XXXX million in 2020 at a CAGR of XX.X% in the coming years, i.e., 2021-30. Due to the rising healthcare expenditure on sexual wellness, the demand for erectile dysfunction drugs is experiencing an escalating demand. The development of novel drug formulations is propelling the market growth further. Additionally, there is a high demand for these drugs from the elderly population as they have hormonal imbalances such as a reduction in libido which is also contributing to the growth of the erectile dysfunction market.
In October 2018, Teva Pharmaceutical launched a generic version of Cialis in the U.S., which is used for the treatment of erectile dysfunction.
In May 2017, Lupin Ltd. launched Cialis, an erectile dysfunction drug through a licensing agreement with Eli Lilly and Company. With this alliance, Eli Lilly will be responsible for manufacturing and importing the product.
Viagra (sildenafil citrate) segment to grow with the highest CAGR during 2021-30
The global Erectile Dysfunction Drugs market is segmented by drug type into Viagra (sildenafil citrate), Cialis (Tadalafil), and Staxyn/Levitra (vardenafil), Stendra/Spedra (avanafil), Zydena (udenafil), Vitaros (Alprostadil Cream), and Others. Viagra (sildenafil citrate), the segment held the largest market share of XX.X% in the year 2020 owing to its large number of sales worldwide over other drugs. Due to its longer duration of action and lesser incidences of adverse effects such as vision problems and muscle pain, it is preferred over other drugs.
The global Erectile Dysfunction Drugs market is divided by Mode of Administration into Oral Medications, Topical Medications, Injections, and Others. Oral Medications, the segment held the largest market share of XX.X% in the year 2020 and will continue to dominate the market in the coming years. Oral medications have several advantages including easy absorption, safety, good patient compliance, versatility, and pain avoidance owing to which it is preferred over other routes of administration.
The global Erectile Dysfunction Drugs market is divided by Distribution channels into Hospital Pharmacies, Retail Pharmacies, and Online Sales. Retail Pharmacies, the segment held the largest market share of XX.X% in the year 2020 and will continue to dominate the market in the coming years as erectile dysfunction drugs are easily available at these stores. Both urban and rural consumers have access to retail pharmacies.
Increasing adoption of the sedentary lifestyle
The rising adoption of a sedentary lifestyle is resulting in the high growth of obesity, cardiovascular diseases, and diabetes, leading to complications such as erectile dysfunction. Poor lifestyle choices, smoking, and alcoholism increase the risk of erectile dysfunction which in turn is boosting the overall growth of the erectile dysfunction drug market. Besides, the factors such as the rise in the geriatric population and life expectancy are also driving the demand for erectile dysfunction drugs.
Development of new drug formulations
Many firms in the erectile dysfunction drugs industry are introducing new drug delivery methods such as the use of pellets and creams. In treating erectile dysfunction, pellets and creams can have more effectiveness and enhanced performance, and they are both more effective and safer to use. Furthermore, the advent of novel formulations including injectable and topical gels is anticipated to proliferate the market in the coming years. As an alternative to oral tablets, these formulations are estimated to attract a large number of patients.
Side effects of drugs on health
The consumption of erectile dysfunction drugs may harm health which is likely to impede the market growth. The common side effects include headache, nasal congestion, vision problems, dizziness, and diarrhea. Moreover, patients with cardiovascular disease have more risk as these drugs can cause a drop in blood pressure.
Company Overview, Business Strategy, Key Product Offerings, Financial Performance, Key Performance Indicators, Risk Analysis, Recent Development, Regional Presence, SWOT Analysis
The global Erectile Dysfunction Drugs Market is segmented based on regional analysis into five major regions. These include North America, Latin America, Europe, Asia Pacific, the Middle East, and Africa. Global Erectile Dysfunction Drugs Market in North America held the largest market share of XX.X% in the year 2020. North America will continue to dominate the global Erectile Dysfunction Drugs market owing to rising healthcare expenditure, growing geriatric population, and high life expectancy. Also, increasing consumer awareness and education in the region is anticipated to fuel the growth of the market.
Global Erectile Dysfunction Drugs Market is further segmented by region into:
North America Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – the United States and Canada
Latin America Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – Mexico, Argentina, Brazil, and Rest of Latin America
Erectile Dysfunction Drugs Market Segments:
By Drug type
Select License Type
US : +1 (716) 218-3733
UK : +44 (208) 1235555
Select License Type
FATPOS CLIENT Appriciation DURING THE PROJECT